Literature DB >> 35253265

Model-assisted analyses of longitudinal, ordinal outcomes with absorbing states.

Jonathan S Schildcrout1, Frank E Harrell1, Patrick J Heagerty2, Sebastien Haneuse3, Chiara Di Gravio1, Shawn P Garbett1, Paul J Rathouz4, Bryan E Shepherd2.   

Abstract

Studies of critically ill, hospitalized patients often follow participants and characterize daily health status using an ordinal outcome variable. Statistically, longitudinal proportional odds models are a natural choice in these settings since such models can parsimoniously summarize differences across patient groups and over time. However, when one or more of the outcome states is absorbing, the proportional odds assumption for the follow-up time parameter will likely be violated, and more flexible longitudinal models are needed. Motivated by the VIOLET Study (Ginde et al), a parallel-arm, randomized clinical trial of Vitamin D 3 in critically ill patients, we discuss and contrast several treatment effect estimands based on time-dependent odds ratio parameters, and we detail contemporary modeling approaches. In VIOLET, the outcome is a four-level ordinal variable where the lowest "not alive" state is absorbing and the highest "at-home" state is nearly absorbing. We discuss flexible extensions of the proportional odds model for longitudinal data that can be used for either model-based inference, where the odds ratio estimator is taken directly from the model fit, or for model-assisted inferences, where heterogeneity across cumulative log odds dichotomizations is modeled and results are summarized to obtain an overall odds ratio estimator. We focus on direct estimation of cumulative probability model (CPM) parameters using likelihood-based analysis procedures that naturally handle absorbing states. We illustrate the modeling procedures, the relative precision of model-based and model-assisted estimators, and the possible differences in the values for which the estimators are consistent through simulations and analysis of the VIOLET Study data.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  absorbing state; longitudinal data; marginalized models; ordinal responses; partial proportional odds; proportional odds; randomized clinical trial

Mesh:

Year:  2022        PMID: 35253265      PMCID: PMC9232888          DOI: 10.1002/sim.9366

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.497


  14 in total

1.  Marginally specified logistic-normal models for longitudinal binary data.

Authors:  P J Heagerty
Journal:  Biometrics       Date:  1999-09       Impact factor: 2.571

2.  Prediction using partly conditional time-varying coefficients regression models.

Authors:  M S Pepe; P Heagerty; R Whitaker
Journal:  Biometrics       Date:  1999-09       Impact factor: 2.571

3.  Marginalized transition models and likelihood inference for longitudinal categorical data.

Authors:  Patrick J Heagerty
Journal:  Biometrics       Date:  2002-06       Impact factor: 2.571

4.  Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design.

Authors:  L Frison; S J Pocock
Journal:  Stat Med       Date:  1992-09-30       Impact factor: 2.373

5.  Longitudinal Data with Follow-up Truncated by Death: Match the Analysis Method to Research Aims.

Authors:  Brenda F Kurland; Laura L Johnson; Brian L Egleston; Paula H Diehr
Journal:  Stat Sci       Date:  2009       Impact factor: 2.901

6.  Regression analysis of longitudinal binary data with time-dependent environmental covariates: bias and efficiency.

Authors:  Jonathan S Schildcrout; Patrick J Heagerty
Journal:  Biostatistics       Date:  2005-05-25       Impact factor: 5.899

7.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

8.  Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step toward Pragmatism in Benefit:risk Evaluation.

Authors:  Scott R Evans; Dean Follmann
Journal:  Stat Biopharm Res       Date:  2016-12-06       Impact factor: 1.452

9.  The trend odds model for ordinal data.

Authors:  Ana W Capuano; Jeffrey D Dawson
Journal:  Stat Med       Date:  2012-12-06       Impact factor: 2.373

10.  Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes.

Authors:  David Benkeser; Iván Díaz; Alex Luedtke; Jodi Segal; Daniel Scharfstein; Michael Rosenblum
Journal:  Biometrics       Date:  2020-10-11       Impact factor: 1.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.